When Does a Medical Clinic Become a Product Distributor? The Hidden Liability of Dispensing Peptides, Supplements, Hormones, and Biologics
News & Posts When Does a Medical Clinic Become a Product Distributor? The Hidden Liability of Dispensing Peptides, Supplements, Hormones, and Biologics A medical clinic
Before Your Clinic Buys Peptides, Exosomes, or Biologics: Important Vendor-Due-Diligence Questions
News & Posts Before Your Clinic Buys Peptides, Exosomes, or Biologics: Important Vendor-Due-Diligence Questions Before purchasing peptides, exosomes, or biologics, clinics must conduct thorough vendor
A Patient Adverse Event Has Occurred: A Response Plan for Clinics and Biologics Suppliers
News & Posts A Patient Adverse Event Has Occurred: A Response Plan for Clinics and Biologics Suppliers When a patient adverse event occurs, clinics must
Are Stem Cells, Exosomes, and Wharton’s Jelly FDA Approved? What Clinics and Biologics Companies Need to Know About Liability
News & Posts Are Stem Cells, Exosomes, and Wharton’s Jelly FDA Approved? What Clinics and Biologics Companies Need to Know About Liability The regulatory status
Umbilical Cord Stem Cells, Cord Blood, and Wharton’s Jelly: Key Differences and Insurance Risks for Clinics and Biologics Companies
News & Posts Umbilical Cord Stem Cells, Cord Blood, and Wharton’s Jelly: Key Differences and Insurance Risks for Clinics and Biologics Companies Umbilical cord products,
Wharton’s Jelly vs Stem Cells: Insurance, Product Liability, and FDA Risk for Regenerative Medicine Businesses
News & Posts Wharton’s Jelly vs Stem Cells: Insurance, Product Liability, and FDA Risk for Regenerative Medicine Businesses Wharton’s Jelly, a gelatinous substance derived from
How to Review Insurance Coverage for a Regenerative Medicine or Biologics Business
News & Posts Reviewing insurance coverage for a regenerative medicine or biologics business requires a methodical approach. Identifying specific risks, such as biologics liability and
Why Regenerative Medicine Clinics Should Review Product Liability Before Selling Supplements, Peptides, or Protocol Bundles
News & Posts Why Regenerative Medicine Clinics Should Review Product Liability Before Selling Supplements, Peptides, or Protocol Bundles Regenerative medicine clinics face unique challenges when
From Supplement Brand to Regenerative Medicine Channel: Liability Risks When Nutraceuticals Move into Clinics
News & Posts From Supplement Brand to Regenerative Medicine Channel: Liability Risks When Nutraceuticals Move into Clinics The shift of nutraceuticals into regenerative medicine clinics
When Supplement Brands Use Regenerative Medicine Language: Why Product Liability May Be More Complex Than You Think
News & Posts When Supplement Brands Use Regenerative Medicine Language: Why Product Liability May Be More Complex Than You Think The use of regenerative medicine